World Allergy Organization Journal

Papers
(The median citation count of World Allergy Organization Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee121
Managing food allergy: GA2LEN guideline 202284
Air pollution and indoor settings74
Allergy and immunology in young children of Japan: The JECS cohort64
Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence56
Relationship between blood eosinophil levels and COVID-19 mortality52
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update48
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management48
Update on latex allergy: New insights into an old problem44
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions39
A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia37
Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review37
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers36
DRESS syndrome: A literature review and treatment algorithm33
A systematic review of infant feeding food allergy prevention guidelines – can we AGREE?33
Food labeling issues for severe food allergic patients33
Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions33
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement26
Inborn errors of immunity with atopic phenotypes: A practical guide for allergists25
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation25
Current and emerging biologic therapies targeting eosinophilic disorders25
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases25
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy24
Incidence and timing of offspring asthma, wheeze, allergic rhinitis, atopic dermatitis, and food allergy and association with maternal history of asthma and allergic rhinitis23
The US population-level burden of cow's milk allergy22
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both22
An update on the prevalence, chronicity, and severity of atopic dermatitis and the associated epidemiological risk factors in the Singapore/Malaysia Chinese young adult population: A detailed descript22
Severe asthma: One disease and multiple definitions22
Recent advances in the management of nut allergy21
Biologics and global burden of asthma: A worldwide portrait and a call for action21
Variability of grass pollen allergy symptoms throughout the season: Comparing symptom data profiles from the Patient's Hayfever Diary from 2014 to 2016 in Vienna (Austria)20
The rationale for development of ligelizumab in food allergy19
The role of environmental allergen control in the management of asthma18
Psychological impact of the COVID-19 pandemic on patients with allergic diseases18
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital18
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments18
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group18
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients17
Risks and safety of biologics: A practical guide for allergists17
Allergic diseases in infancy: I - Epidemiology and current interpretation17
Economic burden of severe asthma treatment: A real-life study17
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)17
Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review17
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's 17
Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts17
Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use17
Prevalence of asthma and allergies among children in the United Arab Emirates: A cross-sectional study16
Harmonizing allergy care–integrated care pathways and multidisciplinary approaches16
Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients16
The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence16
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study16
Expert consensus on the use of omalizumab in chronic urticaria in China15
Dupilumab: An emerging therapy in allergic fungal rhinosinusitis15
An updated prevalence of asthma, its phenotypes, and the identification of the potential asthma risk factors among young Chinese adults recruited in Singapore15
Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)15
Prevalence and risk factors of allergic rhinitis and asthma in the southern edge of the plateau grassland region of northern China: A cross-sectional study15
Pediatric usage of Omalizumab: A promising one14
Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema14
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics13
Oral immunotherapy for food allergy: Translation from studies to clinical practice?13
Food allergies and allergens: Characterization and perceptions among diagnosed food allergic individuals in Lebanon13
The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 201912
Allergenicity assessment and allergen profile analysis of different Chinese wheat cultivars12
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study12
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey12
Hydrolyzed rice formula for dietary management of infants with cow's milk allergy12
Allergic rhinitis in Chinese young adults from the Singapore/Malaysia cross-sectional genetics epidemiology study (SMCGES) cohort: Prevalence, patterns, and epidemiology of allergic rhinitis12
Latin American anaphylaxis registry12
Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: Efficacy and safety12
Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases12
Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective12
Effect of environmental exposures on allergen sensitization and the development of childhood allergic diseases: A large-scale population-based study12
Allergic rhinitis aggravated by air pollutants in Latin America: A systematic review12
Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma12
Utility of biomarkers in the diagnosis and monitoring of asthmatic children12
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life12
Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study11
Urban vs rural – Prevalence of self-reported allergies in various occupational and regional settings11
Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase I11
Knowledge of healthcare providers in the management of anaphylaxis11
Severity of COVID-19 in hospitalized patients with and without atopic disease11
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review11
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)11
Prenatal vitamin D supplementation and child respiratory health: A systematic review and meta-analysis of randomized controlled trials11
Digital tools in allergy and respiratory care11
Prevalence of asthma symptoms and associated risk factors among adults in Saudi Arabia: A national survey from Global Asthma Network Phase Ⅰ11
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor11
Assessment of perception, attitude, and practice of primary care practitioners towards allergic rhinitis practice guidelines: Development and validation of a new questionnaire11
Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis10
Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status10
Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong – Clinical outcomes, barriers to vaccination, and urgency for reform10
The prevalence and temporal trends of food allergy among preschool children in Northern Thailand between 2010 and 201910
Association of infant antibiotic exposure and risk of childhood asthma: A meta-analysis10
Predicting allergic diseases in children using genome-wide association study (GWAS) data and family history10
The disease burden and quality of life of chronic cough patients in South Korea and Taiwan10
Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy10
Lipid transfer protein syndrome: How to save a life through careful education10
Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps9
WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways9
Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life9
Variability of Type 2 inflammatory markers guiding biologic therapy of severe asthma: A 5-year retrospective study from a single tertiary hospital9
Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting S9
Age-related differences in characteristics of anaphylaxis in Chinese children from infancy to adolescence9
The changes of clinical and histological characteristics of chronic rhinosinusitis in 18 years: Was there an inflammatory pattern shift in southern China?9
Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis9
WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-199
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy9
Atopic dermatitis in the COVID-19 era: Results from a web-based survey9
Unanswered questions on the use of biologics in pediatric asthma9
Linking cross-reactivity clusters of food and respiratory allergens in PAMD@ to asthma and duration of allergy8
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic8
The efficacy of a novel smart watch on medicine adherence and symptom control of allergic rhinitis patients: Pilot study8
75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results8
Erratum to "IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" [World Allergy Organ J 13/2 (2020) 100080]8
Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis8
Association of asthma comorbidity with poor prognosis of coronavirus disease 20198
Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps8
Epidemiologic features and burden of atopic dermatitis in adolescent and adult patients: A cross-sectional multicenter study8
WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-198
Negative impact of penicillin allergy labels on antibiotic use in hospitalized patients in Chinese Mainland8
Pollen respiratory allergy: Is it really seasonal?8
Naples prognostic score as a novel prognostic prediction indicator in adult asthma patients: A population-based study7
Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions7
Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI7
IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma7
Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic7
Component-resolved diagnosis in adult patients with food-dependent anaphylaxis7
Prospective analysis of clinical evolution in chronic urticaria: Persistence, remission, recurrence, and pruritus alone7
CircRNA expression profiles and circRNA-miRNA-mRNA crosstalk in allergic rhinitis7
Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from t7
Smoking behavior might affect allergic rhinitis and vasomotor rhinitis differently: A mendelian randomization appraisal7
Prevalence of self-reported food allergy among adults in Jiangxi, China7
A systematic review of quality and consistency of clinical practice guidelines on the primary prevention of food allergy and atopic dermatitis7
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations7
Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update7
Multi-omics profiling approach in food allergy7
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis7
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection7
PEG allergy — A COVID-19 pandemic-made problem? A German perspective7
Decreasing ten-year (2008–2018) trends of the prevalence of childhood asthma and air pollution in Southern Taiwan7
Dyslipidemia among allergic rhinitis patients: Frequency and risk factors7
High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs7
Prevalence and risk factors of allergic rhinitis among Chinese adults: A nationwide representative cross-sectional study7
Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)☆7
Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 20237
Increasing anaphylaxis events in Western Australia identified using four linked administrative datasets7
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines update – VI – A quality appraisal with the AGREE II instrument7
Identifying gene network patterns and associated cellular immune responses in children with or without nut allergy7
Active smoking effect in allergic rhinitis7
The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity6
The food allergy COPE inventory: Adaptation and psychometric properties6
Food allergies and allergens in Lebanon: Characterization and perceptions toward labeling6
The multifactorial impact of receiving a hereditary angioedema diagnosis6
Impact of asthma in Europe: A comparison of web search data in 21 European countries6
Identification of an immunodominant IgE epitope of Der p 39, a novel allergen of Dermatophagoides pteronyssinus6
The role of allergen-specific IgE in predicting allergic symptoms on dog and cat exposure among Korean pet exhibition participants6
Safety of direct oral provocation testing using the Amoxicillin-2-step-challenge in children with history of non-immediate reactions to amoxicillin6
Allergy education and training for physicians6
Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema6
Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL6
Efficacy of non-sedating H1-receptor antihistamines in adults and adolescents with chronic cough: A systematic review6
Plasma-derived extracellular vesicles discriminate type-1 allergy subjects from non-allergic controls6
Prevalence of skin diseases in children 1 to 6 years old in the city of Bogota, Colombia6
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care6
Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience6
Revisiting differences between atopic and non-atopic asthmatics: When age is shaping airway inflammatory profile6
Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects6
SARS-COV-2, can you be over it?6
Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I6
Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma6
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry6
Omalizumab is effective in nasal polyposis with or without asthma, a real-life study6
Usage patterns of oral H1-antihistamines in 10 European countries: A study using MASK-air® and Google Trends real-world data5
Early-life weight gain is associated with non-atopic asthma in childhood5
Prevalence, severity, and risk factors of allergic rhinitis among schoolchildren in Saudi Arabia: A national cross-sectional study, 20195
Ambient particulate matter associates with asthma in high altitude region: A population-based study5
Skin manifestations in pediatric patients with primary immunodeficiency diseases (PIDs) in a tertiary care hospital in Colombia5
Prevalence of asthma symptoms and associated factors in adolescents and adults in southern Brazil: A Global Asthma Network Phase I study5
Food allergy in Sri Lanka – A comparative study5
Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study5
Omalizumab may protect allergic patients against COVID-19: A systematic review5
Allergen Immunotherapy management during vaccinations: An international survey5
Cord blood 25(OH)D3, cord blood total immunoglobulin E levels, and food allergies in infancy: A birth cohort study in Chongqing, China5
Impact of COVID-19 pandemic on asthma symptoms and management: A prospective analysis of asthmatic children in Ecuador5
Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media5
Implication of allergy and atopy in IgG4-related disease5
A narrative review of recent literature of the quality of life in hereditary angioedema patients5
Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy5
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy5
Mollusk allergy in shrimp-allergic patients: Still a complex diagnosis. An Italian real-life cross-sectional multicenter study5
Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A r5
Hypersensitivity reactions to iodinated radiocontrast media: Cluster analysis reveals distinct clinical phenotypes4
“Real-life” management of patients with severe asthma in the biologics era: Can we do better?4
Proteomic profiling of commercial dust mite skin prick test solutions and allergy vaccines from India4
Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season4
Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study4
The effect of asthma specialist intervention on asthma control among adults4
A clinical pathway for the diagnosis of sesame allergy in children4
May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?4
Impact of airborne pollen concentration and meteorological factors on the number of outpatients with allergic rhinitis4
Hypertensive disorders of pregnancy and risk of allergic conditions in children: Findings from the Japan Environment and Children's study (JECS)4
“Chronic urticaria and obstructive sleep apnea: Is there a significant association?”4
Serum IgE profiles in Chinese pollinosis patients with grass pollen sensitisation4
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XII – Recommendations on milk formula supplements with and without probiotics4
Prenatal and perinatal risk factors of food allergy in Taiwanese young children4
A mathematical model for the prediction of the prevalence of allergies in Zimbabwe4
Developing nomograms for identifying allergic rhinitis among chronic rhinitis: A real-world study4
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps4
Development of an action plan for acute food protein–induced enterocolitis syndrome in Japan4
The clinical burden of food allergies: Insights from the Food Allergy Research & Education (FARE) Patient Registry4
Monitoring disease activity of pollen allergies: What crowdsourced data are telling us4
Anaphylaxis in older adult patients: a 10-year retrospective experience3
Severe asthma treatment patterns: A multicenter observational study in the Gulf region3
Phenotypic clusters on computed tomography reflects asthma heterogeneity and severity3
Osteopontin mediated eosinophils activation by group II innate lymphoid cells3
Trends in incidence of atopic disorders in children and adolescents - Analysis of German claims data3
Cancer: Still a contraindication for allergen immunotherapy?3
A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th13
Chromosome-level assembly of Dermatophagoides farinae genome and transcriptome reveals two novel allergens Der f 37 and Der f 393
Comparison of recent anaphylaxis diagnostic criteria in real life: Can more patients be diagnosed as having anaphylaxis?3
Assessing the national burden of allergic asthma by web-search data, pollen counts, and drug prescriptions in Germany and Sweden3
Asthma and prognosis of coronavirus disease 20193
Allergic diseases in infancy II–oral tolerance and its failure3
Sensitization to oil palm pollen associates with risks and severity of allergic diseases3
Eczema among adolescents in Kuwait: Prevalence, severity, sleep disturbance, antihistamine use, and risk factors3
Association between dietary antioxidant intakes and chronic respiratory diseases in adults3
Dogmas, challenges, and promises in phase III allergen immunotherapy studies3
Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study a3
Global disparities in availability of epinephrine auto-injectors3
The Positive and Negative Affect Schedule — Food Allergy (PANAS-FA): Adaptation and psychometric properties3
Incidence, triggering factors, symptoms, and treatment of anaphylaxis in a pediatric hospital3
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab3
Classification of atopic dermatitis phenotypes according to allergic sensitization by cluster analysis3
Quality and consistency of clinical practice guidelines on the prevention of food allergy and atopic dermatitis: Systematic review protocol3
Comparison of two diagnostic criteria in the diagnosis of anaphylaxis in a tertiary adult allergy clinic3
Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee3
The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels3
Changes in peripheral blood eosinophils may predict colorectal cancer – A retrospective study3
Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience3
Clinical history in suspected cases of immediate allergy to beta-lactam3
IgE-immunoadsorption for severe allergy to multiple foods: A case series of five children3
Paediatric anaphylaxis in South Africa3
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria3
Efficacy and safety of subcutaneous immunotherapy with a mixture of glutaraldehyde-modified extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae, and Blomia tropicalis3
Drug hypersensitivity in drug-resistant tuberculosis3
0.084928035736084